Melatonin blocks oxidative stress-induced increased asymmetric dimethylarginine

Free Radical Biology and Medicine

Volumn 49, Issue 6, 2010, Pages 1088-1098

  Tain, You Lin ^a   Kao, Ying Hsien ^b   Hsieh, Chih Sung ^c   Chen, Chih Cheng ^a   Sheen, Jiunn Ming ^a   Lin, I Chun ^a   Huang, Li Tung ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b I SHOU UNIVERSITY   (Taiwan)

^c PINGTUNG CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

Asymmetric dimethylarginine; Free radicals; Melatonin; Nitric oxide; Oxidative stress

Indexed keywords

DIMETHYLARGININE DIMETHYAMINOHYDROLASE 1; DIMETHYLARGININE DIMETHYAMINOHYDROLASE 2; HYDROGEN PEROXIDE; MELATONIN; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE SYNTHASE INHIBITOR; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; COMPETITIVE INHIBITION; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ENZYME ACTIVITY; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CULTURE; LIVER PROTECTION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

RATTUS;

EID: 77955512287     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2010.06.029     Document Type: Article

References (35)

1. Vallance P., Leone A., Calver A., Collier J., Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992, 339:572-575.
2. Cooke J.P. ADMA: its role in vascular disease. Vasc. Med. 2005, 10:S11-S17.
3. Böger R.H. Asymmetric dimethylarginine (ADMA): a novel risk marker in cardiovascular medicine and beyond. Ann. Med. 2006, 38:126-136.
4. Wang D., Strandgaard S., Iversen J., Wilcox C.S. Asymmetric dimethylarginine, oxidative stress, and vascular nitric oxide synthase in essential hypertension. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 296:R195-R200.
5. Baylis C. Nitric oxide deficiency in chronic kidney disease. Am. J. Physiol. Renal Physiol. 2008, 294:F1-F9.
6. Laleman W., Omasta A., Van De Casteele M., Zeegers M., Vander Elst I., Van Landeghem L., Severi T., Van Pelt J., Roskams T., Fevery J., Nevens F. A role for asymmetric dimethylarginine in the pathophysiology of portal hypertension in rats with biliary cirrhosis. Hepatology 2005, 42:1382-1390.
7. Tain Y.L., Hsieh C.S., Chen C.C., Sheen J.M., Lee C.T., Huang L.T. Melatonin prevents increased asymmetric dimethylarginine in young rats with bile duct ligation. J. Pineal Res. 2010, 48:212-221.
8. Teerlink T., Luo Z., Palm F., Wilcox C.S. Cellular ADMA: regulation and action. Pharmacol. Res. 2009, 60:448-460.
9. Devés R., Boyd C.A. Transporters for cationic amino acids in animal cells: discovery, structure, and function. Physiol. Rev. 1998, 78:487-545.
10. Nijveldt R.J., Teerlink T., Siroen M.P., Van Lambalgen A.A., Rauwerda J.A., Van Leeuwen P.A. The liver is an important organ in the metabolism of asymmetrical dimethylarginine (ADMA). Clin. Nutr. 2003, 22:17-22.
11. Ljubuncic P., Tanne Z., Bomzon A. Evidence of a systemic phenomenon for oxidative stress in cholestatic liver disease. Gut 2000, 47:710-716.
12. Huang L.T., Tiao M.M., Tain Y.L., Chen C.C., Hsieh C.S. Melatonin ameliorates bile duct ligation-induced systemic oxidative stress and spatial memory deficits in developing rats. Pediatr. Res. 2009, 65:176-180.
13. Orellana M., Rodrigo R., Thielemann L., Guajardo V. Bile duct ligation and oxidative stress in the rat: effects in liver and kidney. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2000, 126:105-111.
14. Sydow K., Munzel T. ADMA and oxidative stress. Atherosclerosis 2003, 4:41-51.
15. Grintzalis K., Papapostolou I., Assimakopoulos S.F., Mavrakis A., Faropoulos K., Karageorgos N., Georgiou C., Chroni E., Konstantinou D. Time-related alterations of superoxide radical levels in diverse organs of bile duct-ligated rats. Free Radic. Res. 2009, 43:803-808.
16. Palm F., Onozato M.L., Luo Z., Wilcox C.S. Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H3227-H3245.
17. Tain Y.L., Baylis C. Determination of dimethylarginine dimethylaminohydrolase activity in the kidney. Kidney Int. 2007, 72:886-889.
18. Tan D.X., Manchester L.C., Terron M.P., Flores L.J., Reiter R.J. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species?. J. Pineal Res. 2007, 42:28-42.
19. Allegra M., Reiter R.J., Tan D.X., Gentile C., Tesoriere L., Livrea M.A. The chemistry of melatonin's interaction with reactive species. J. Pineal Res. 2003, 34:1-10.
20. Manda K., Ueno M., Anzai K. AFMK, a melatonin metabolite, attenuates X-ray-induced oxidative damage to DNA, proteins and lipids in mice. J. Pineal Res. 2007, 42:386-393.
21. Tomás-Zapico C., Coto-Montes A. A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes. J. Pineal Res. 2005, 39:99-104.
22. Erşahin M., Sehirli O., Toklu H.Z., Süleymanoglu S., Emekli-Alturfan E., Yarat A., Tatlidede E., Yeǧen B.C., Sener G. Melatonin improves cardiovascular function and ameliorates renal, cardiac and cerebral damage in rats with renovascular hypertension. J. Pineal Res. 2009, 47:97-106.
23. Tain Y.L., Muller V., Szabo A.J., Erdely A., Smith C., Baylis C. Renal cortex neuronal nitric oxide synthase in response to rapamycin in kidney transplantation. Nitric Oxide 2008, 18:80-86.
24. Kao Y.H., Goto S., Jawan B., Nakano T., Hsu L.W., Lin Y.C., Pan M.C., Lai C.Y., Sun C.K., Cheng Y.F., Tai M.H., Huang H.T., Chen C.L. Heat preconditioning ameliorates hepatocyte viability after cold preservation and rewarming, and modulates its immunoactivity. Transplant. Immunol. 2008, 18:220-231.
25. Weis M., Kledal T.N., Lin K.Y., Panchal S.N., Gao S.Z., Valantine H.A., Mocarski E.S., Cooke J.P. Cytomegalovirus infection impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine in transplant arteriosclerosis. Circulation 2004, 109:500-505.
26. Tain Y.L., Hsieh C.S., Lin I.C., Chen C.C., Sheen J.M., Huang L.T. Effects of maternal L-citrulline supplementation on renal function and blood pressure in offspring exposed to maternal caloric restriction: the impact of nitric oxide pathway. Nitric Oxide 2010, 23:34-41.
27. Gardner P.R., Raineri I., Epstein L.B., White C.W. Superoxide radical and iron modulate aconitase activity in mammalian cells. J. Biol. Chem. 1995, 270:13399-13405.
28. Buetler T.M., Krauskopf A., Ruegg U.T. Role of superoxide as a signaling molecule. News Physiol. Sci. 2004, 19:120-123.
29. Li J., Wilson A., Gao X., Kuruba R., Liu Y., Poloyac S., Pitt B., Xie W., Li S. Coordinated regulation of dimethylarginine dimethylaminohydrolase-1 and cationic amino acid transporter-1 by farnesoid X receptor in mouse liver and kidney and its implication in the control of blood levels of asymmetric dimethylarginine. J. Pharmacol. Exp. Ther. 2009, 331:234-243.
30. Maas R. Pharmacotherapies and their influence on asymmetric dimethylarginine (ADMA). Vasc. Med. 2005, 10:S49-S57.
31. Monitlla P., Cruz A., Padillo F.J., Túnez I., Gascon F., Muñoz M.C., Gómez M., Pera C. Melatonin versus vitamin E as protective treatment against oxidative stress after extra-hepatic bile duct ligation in rats. J. Pineal Res. 2001, 31:138-144.
32. Tan D.X., Manchester L.C. Reiter, R.J; Plummer, B.F.; Limson, J.; Weintraub, S.T.; Qi, W. Melatonin directly scavenges hydrogen peroxide: a potentially new metabolic pathway of melatonin biotransformation. Free Radic. Biol. Med. 2000, 29:1177-1185.
33. Wang D., Gill P.S., Chabrashvili T., Onozato M.L., Raggio J., Mendonca M., Dennehy K., Li M., Modlinger P., Leiper J., Vallance P., Adler O., Leone A., Tojo A., Welch W.J., Wilcox C.S. Isoform-specific regulation by N(G), N(G)-dimethylarginine dimethylaminohydrolase of rat serum asymmetric dimethylarginine and vascular endothelium-derived relaxing factor/NO. Circ. Res. 2007, 101:627-635.
34. Knipp M., Charnock J.M., Garner C.D., Vasák M. Structural and functional characterization of the Zn(II) site in dimethylargininase-1 (DDAH-1) from bovine brain: Zn(II) release activates DDAH-1. J. Biol. Chem. 2001, 276:40449-40456.
35. Oztürk G., Akbulut K.G., Afrasyap L. Age-related changes in tissue and plasma zinc levels: modulation by exogenously administered melatonin. Exp. Aging Res. 2008, 34:453-462.